These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 10435906)

  • 21. Biocompatibility and acute renal failure.
    Schiffl H
    Lancet; 2000 Jan; 355(9200):312; author reply 313-4. PubMed ID: 10675089
    [No Abstract]   [Full Text] [Related]  

  • 22. Complement activation and leucopenia on cellulosic haemodialyzers: influence of the membrane area and role of hydroxyl moieties.
    Goldman M; Lietaer N; Lambert P; Thayse C; Vanherweghem JL
    Life Support Syst; 1987; 5(4):317-22. PubMed ID: 3501504
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cellulosic versus synthetic membranes: a reasonable comparison?
    Baurmeister U; Vienken J; Ansorge W; Luttrell A
    Artif Organs; 1989 Feb; 13(1):52-7. PubMed ID: 2653285
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Haemodialysis activates phospholipase A2 enzyme.
    Vishwanath BS; Fux CA; Uehlinger DE; Frey BM; Franson RC; Frey FJ
    Nephrol Dial Transplant; 1996 Jan; 11(1):109-16. PubMed ID: 8649616
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biocompatible dialysis membranes do not reduce plasma leptin levels.
    Wright MJ; Woodrow G; Young G; Brownjohn AM; Turney JH
    Nephrol Dial Transplant; 2000 Jun; 15(6):925-6. PubMed ID: 10831667
    [No Abstract]   [Full Text] [Related]  

  • 26. Pathogenesis of delayed kidney graft function: role of endothelin-1, thromboxane B2, and leukotriene B4.
    Schilling M; Holzinger F; Friess H; Seiler C; Büchler MW
    Transplant Proc; 1996 Feb; 28(1):304-5. PubMed ID: 8644233
    [No Abstract]   [Full Text] [Related]  

  • 27. [Clinical study of biocompatibility of dialysis membranes made from non-modified and modified cellulose].
    Opatrný K; Sulková S; Vít L; Vienken J; Körwer-Uhlenbusch I; Sefrna F; Válek A; Bláha J
    Cas Lek Cesk; 1992 Aug; 131(15):457-61. PubMed ID: 1423453
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structure of dialysis membranes and long-term clinical outcome.
    Bonomini V; Coli L; Scolari MP; Stefoni S
    Am J Nephrol; 1995; 15(6):455-62. PubMed ID: 8546165
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Eicosanoid release as laboratory indicator of biocompatibility.
    Mahiout A; Jörres A; Schultze G; Meinhold H; Kessel M
    Artif Organs; 1989 Jun; 13(3):251-4. PubMed ID: 2504134
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Content of arachidonic acid metabolites in blood and saliva of children with bronchial asthma].
    Mozalevskiĭ AF; Travianko TD; Iakovlev AA; Smirnova EA; Novikova NP; Sapa IIu
    Ukr Biokhim Zh (1978); 1997; 69(5-6):162-8. PubMed ID: 9606840
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Does the biocompatibility of the hemodialysis membrane influence the prognosis of acute renal insufficiency?].
    Tielemans C; Gastaldello K; Melot C; Kahn RJ; Vanherweghem JL
    Nephrologie; 1998; 19(2):89-91. PubMed ID: 9592779
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Functional changes in the blood neutrophils in dilated cardiomyopathy and their correction with low-intensity laser radiation].
    Kipshidze NN; Khomeriki SG; Kubatiev AA; Naumov VG; Shliapnikov VN
    Ter Arkh; 1992; 64(9):78-81. PubMed ID: 1336230
    [No Abstract]   [Full Text] [Related]  

  • 33. Aspects of biocompatibility of two different dialysis membranes: cuprophane and polysulfone.
    Amato M; Salvadori M; Bergesio F; Messeri A; Filimberti E; Morfini M
    Int J Artif Organs; 1988 May; 11(3):175-80. PubMed ID: 3261279
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biocompatibility of hemodialysis membranes: a study in healthy subjects.
    Gutierrez A; Alvestrand A; Bergström J; Beving H; Lantz B; Henderson LW
    Blood Purif; 1994; 12(2):95-105. PubMed ID: 7826580
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The effect of the primary and repeated use of dialyzers with different membranes on the degree of dialysis-induced leukopenia].
    Strokov AG; Baeva LB; Levitskiĭ ER
    Med Tekh; 1990; (5):16-8. PubMed ID: 2273963
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficiency and biocompatibility of membranes.
    Churchill DN
    Contrib Nephrol; 1995; 113():60-71. PubMed ID: 7712723
    [No Abstract]   [Full Text] [Related]  

  • 37. Biocompatibility and the clinical choice of dialysis membranes.
    Mujais SK; Ivanovich P; Bereza LA; Vidovich M
    Contrib Nephrol; 1995; 113():101-9. PubMed ID: 7712716
    [No Abstract]   [Full Text] [Related]  

  • 38. [Experience with the multiple use of dialyzers].
    Strokov AG; Poz IaL; Baeva LB; Levitskiĭ ER; Annenkov AE; Rud'ko IA; Kubatiev AA
    Ter Arkh; 1994; 66(6):60-5. PubMed ID: 7940372
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Arachidonate cascade, apoptosis, and vitamin E in peripheral blood mononuclear cells from hemodialysis patients.
    Maccarrone M; Manca-di-Villahermosa S; Meloni C; Massoud R; Mascali A; Guarina R; Finazzi-Agrò A; Taccone-Gallucci M
    Am J Kidney Dis; 2002 Sep; 40(3):600-10. PubMed ID: 12200813
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interleukin 8 and biocompatibility of dialysis membranes.
    Niwa T; Miyazaki T; Sato M; Kambe F; Tsuzuki T; Uema K; Maeda K; Seo H
    Am J Nephrol; 1995; 15(3):181-5. PubMed ID: 7618641
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.